« Back to Record
Citation APA

Eggermont, A. A., Suciu, S., Santinami, M., Testori, A., Kruit, W. H., Marsden, J., Punt, C., Sales, F., Gore, M., Mackie, R., Kusic, Z., Dummer, R., Hauschild, A., Musat, E., Spatz, A., & Keilholz, U. (2008). Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial. Lancet, 372(9633), 117-126. doi:10.1016/S0140-6736(08)61033-8


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/176187

Eggermont, A. A., Suciu, S., Santinami, M., Testori, A., Kruit, W. H., Marsden, J., Punt, C., Sales, F., Gore, M., Mackie, R., Kusic, Z., Dummer, R., Hauschild, A., Musat, E., Spatz, A., & Keilholz, U. (2008). Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial. Lancet, 372(9633), 117-126. doi:10.1016/S0140-6736(08)61033-8